CANNAPHARMARX, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $-959.3K | $0 |
| Jun 2017 | — | $-959.3K | $0 |
| Sep 2017 | — | $-959.3K | $0 |
| Dec 2017 | — | $-964.3K | $0 |
| Mar 2018 | — | $-964.3K | $0 |
| Jun 2018 | — | $-974.8K | $22.2K |
| Sep 2018 | — | $-1.2M | $682.1K |
| Dec 2018 | $6.6M | $-286.3K | $464.1K |
| Mar 2019 | — | $12.3M | $203.5K |
| May 2019 | $6.8M | — | — |
| Jun 2019 | $7.0M | $11.7M | — |
| Sep 2019 | $7.0M | $12.6M | — |
| Dec 2019 | — | $4.9M | $1.5K |
| Mar 2020 | — | $1.3M | $83.2K |
| Jun 2020 | — | $2.7M | $3.8K |
| Sep 2020 | — | $1.5M | $243.3K |
| Dec 2020 | — | $-8.8M | $335.0K |
| Mar 2021 | — | $-6.9M | $30.1K |
| Jun 2021 | — | $-6.4M | $110.2K |
| Sep 2021 | — | $-6.3M | $112.8K |
| Dec 2021 | — | $-12.9M | $27.8K |
| Mar 2022 | — | $-14.3M | $79.7K |
| Jun 2022 | — | $-14.7M | $5.2K |
| Sep 2022 | — | $-15.0M | $7.5K |
| Dec 2022 | — | $17.3M | $2.3K |
| Mar 2023 | — | $-18.2M | $0 |
| Jun 2023 | — | $-20.1M | $0 |
| Sep 2023 | — | $-20.6M | $0 |
| Dec 2023 | — | $-12.2M | $650 |
| Mar 2024 | — | $-23.5M | $12.1K |
| Jun 2024 | — | $-16.7M | $9.1K |
| Sep 2024 | — | $-16.6M | $7.0K |
| Dec 2024 | — | $-19.8M | $2.2K |
| Mar 2025 | — | $-20.5M | $1.2K |
| Jun 2025 | — | $-22.6M | $17.0K |
| Sep 2025 | — | $-22.5M | $927 |
| Dec 2025 | — | $-30.2M | $1.8K |
| Mar 2026 | — | $-30.3M | $633 |
| Jun 2026 | — | $-30.8M | $555 |